Micron Sees AIDriven Memory Demand Surging as Company Expands Singapore Operations
Wall Street Journals Heard on the Street Unveils 8th Annual StockPicking Contest
QLine Biotech IPO Allotment Expected Today Grey Market Premium at 115
Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales and Item Volume
Bessent Sees Substantial Disinflation Ahead as Warsh Assumes Fed Leadership
Hong Kongs Gold Hub Ambitions Get Boost with New Clearing System Set for July Launch
MTA Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Broader Sentiment
RITM Q1 2026 Earnings Modest EPS Beat Highlights Steady Portfolio Performance
FGSN Q1 2026 Earnings Earnings Miss Sends Notes Lower
AMN Healthcare Q1 2026 Earnings Strong EPS Beat Drives Stock Surge
World Kinect Corporation WKC Q1 2026 Earnings Massive EPS Beat Drives Shares Higher
NewtekOne Inc NEWTI Q1 2026 Earnings EPS Slightly Misses Expectations Bond Price Unchanged
Marwynn Holdings MWYN Holds Steady Near 088 as Traders Eye Key Support and Resistance Levels
Xtant Medical Holdings Holds Near Key Resistance Level After Modest Gain
Acumen Pharmaceuticals ABOS Edges Higher Amid Low Volume Tests Key Resistance Levels
Genesco Inc GCO Surges 37 as Footwear Retailer Tests Resistance at 3887
BrightSpire Capital BRSP Holds Steady at 568 as Trading Range Tightens
SP Global SPGI Dividend Appeal Highlighted as Mobility SpinOff Approaches
zSpace Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent
M Evo Global Acquisition Corp II MEVOU Units Hold at 101 Support and Resistance Levels Define Trading Range
Southern First Bancshares SFST Edges Higher as Stock Consolidates Near Resistance
Old National Bancorp Preferred Shares ONBPO Hold Steady Near Support Levels
ZoomInfo Technologies GTM Slides to 35 as Selling Pressure Intensifies
John Hancock Income Securities Trust JHS Holds Steady at 1102 Amid RangeBound Trading
Korro Bio Inc KRRO Surges 62 as Biotech Stock Tests Key Resistance at 1295
Jaguar Health JAGX Surges 687 as Shares Test Critical Resistance at 327
Aytu BioPharma Rallies as Shares Test Key Resistance Levels